CONTEXT: Commercial announcement of another company acquiring RWE data assets | Patient search and identification meets data aggregation to produce de-identified, enriched, longitudinal data points derived from complex medical data Continue Reading
CONTEXT: Machine learning algorithms and large RWD data sets combining to look for “new” indications for existing compounds. Make the most of what you’ve got is certainly a very cost Continue Reading
CONTEXT: Fairly simplistic article on RWD reporting on an article from an orthopaedic journal | More evidence of the spread of RWR and the newer statistical methods coming into play to Continue Reading
CONTEXT: Ordinarily we wouldn’t post news about RCT studies. However, the thing that caught our eye in this article is the need to point out that the research question they Continue Reading
CONTEXT: Peer reviewed retrospective study of a triple oral combination therapy in PAH | Japan only data. IMPACT: medium READ TIME: 2 mins Quality Level Mean [1 – 10]: 8 Continue Reading
CONTEXT: Short article but nice explainer video on why RWR is so important in oncology research IMPACT: Medium READ TIME: 1 min Quality Level Mean [1 – 10]: 8 1. Continue Reading
CONTEXT: ICER using RWE predominantly for economic reviews and seldom in effectiveness evaluations. IMPACT: mediumREAD TIME: 2 mins Quality Level Mean [1 – 10]: 7 1. “Real-world evidence is used Continue Reading
CONTEXT: Long term treatment effect study of a rare disease (LOPD) | Relatively low patient numbers for RWR, but the findings just as powerful for this rare disease. IMPACT: Continue Reading
CONTEXT: No great surprise the MS patients are at a higher risk of infections, but good use of retrospective data analyses to see exactly what is going on – well Continue Reading
CONTEXT: A company looking to explore new ways to expand the use of RWD in drug development. By utilising the power of RWD to look at treatment models overall, it Continue Reading
